| Early Phase 1 | 5 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Early Phase 1 | ||||
| NCT07203404 | A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With… | SLE | Recruiting | 2026-08-03 |
| NCT06548607 | Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases | SLE (Systemic Lupus) | Recruiting | 2026-03-06 |
| NCT06775912 | Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases | SLE | Recruiting | 2026-02-02 |
| NCT07596680 | CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases | SLE - Systemic Lupus Erythematosus | Not Yet Recruiting | 2026-07-16 |
| NCT07142161 | A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T… | Type 1 Diabetes | Active, Not Recruiting | 2025-08-26 |
Lupus (SLE) (4) · Scleroderma (3) · Diabetes (1) · Multiple Sclerosis (1) · Type 1 Diabetes (1)